Free Access
Review

Table VIII.

Summary table to show transmission between homogeneously treated groups of animals.

Donor
Recipient
Species Vaccine Challenge Days
vaccinated
before
exposure
Clinical
disease
and/or virus
recovery after
challenge
Contact
began
Clinical
disease
and/or virus
recovery
Ref.
Pigs O Taiwan
3 μg/dose
Oil
Homologous
intradermal
inoculation
14 0/5a 1b 0/5 [30]
7 5/5 1 5/5
0 5/5 1 5/5

Pigs O Taiwan
3 μg/dose
Oil
Homologous
intradermal
inoculation
14 0/5 1 0/5 [31]
O Manisa
3 μg/dose
Oil
Heterologous O
Taiwan
intradermal
inoculation
14 0/5 1 0/5
O Taiwan
intradermal
inoculation
0 5/5 1 5/5

Pigs O Taiwan
3 μg/dose
Oil
Homologous
intradermal
inoculation
7 5/5 1 5/5 [36]
O Taiwan

3 μg/dose
Oil
Homologous
intradermal
inoculation
7 5/5 1 3/5
O Taiwan
intradermal
inoculation
0 5/5 1 5/5

Pigs O1 Manisa
5 μg/dose
oil
O/NET/2001
Continuous
durect contact
(1:1)
14 4/6 N/A N/A [46]
0 5/6
O1 Manisa
5 μg/dose
oil
O/NET/2001
direct contact
with 4 pigs for
1day
14 (Ac) 5/5 1 5/5
0 (A) 5/5 1 5/5
14 (B) 4/5 1 4/5
0 (B) 5/5 1 5/5

Cattle
(calves)
O/NET/2001
Continuous
direct contact
with 2 calves
0 (A) 2/2 [45]
0 (B) 2/2
0 (C) 1/2
0 (D) 1/2 N/A N/A
0 (E) 1/2
0 (F) 2/2
 
O1 Manisa
Oil
11 PD50
O/NET/2001
Continuous
direct contact
with 2 calves
14 (A) 1/2
14 (B) 0/2
14 (C) 0/2 N/A N/A
14 (D) 0/2
14 (E) 0/2
14 (F) 0/2

Cattle
(dairy)
O1 Manisa
Oil
9 PD50
 
O/NET/2001
Continuous
direct contact
with 5 cattle
0 (A) 5/5 N/A N/A [47]
0 (B) 5/5
O/NET/2001
Continuous
direct contact
with 5 cattled
14 (A) 0/5
14 (B) 0/5 N/A N/A

Sheep (lambs) O/NET/2001
Continuous
direct contact
with 2 lambs
0 (A) 1/2 [48]
0 (B) 0/2
0 (C) 0/2 N/A N/A
0 (D) 2/2
0 (E) 0/2
0 (F) 2/2
O1 Manisa
Oil
6 PD50
 
O/NET/2001
Continuous
direct contact
with 2 lambsd
14 (G) 0/2
14 (H) 1/2
14 (I) 0/2
14 (J) 0/2
14 (K) 0/2
14 (L) 0/2

Sheep O1 Manisa
? (18
PD50 for
cattle)
Oil
Semi-
heterologous
indirect aerosol
from 3 infectious
pigs for 9 h
10 7/10 2 1/4 [52]
4 8/10 2 1/4
0 8/8 N/A N/A
a

Number of animals clinically diseased or from which virus recovered/total number of animals

b

number of days after vaccinated animals challenged

c

replicate

d

donor animals vaccinated before intranasal inoculation.